The pathogenesis and management of painful diabetic neuropathy: a review
- 12 February 2003
- journal article
- review article
- Published by Wiley in Diabetic Medicine
- Vol. 20 (2) , 88-98
- https://doi.org/10.1046/j.1464-5491.2003.00852.x
Abstract
Painful diabetic neuropathy has always been a challenging complication of diabetes mellitus. Emerging theories suggest that early dysaesthesia associated with painful neuropathy may act as a marker for the development of the ‘at risk’ foot, allowing preventative clinical strategies to be undertaken. The mechanisms of neuropathic pain are complex. The authors’ intentions are to help members of the diabetes care team better understand and appreciate the diverse symptoms reported by patients. The various treatments available for painful neuropathy are discussed in detail. Robust comparative studies on such treatments are, however, unavailable and the authors have designed a logical approach to management based on best current evidence and their own clinical experience.Keywords
This publication has 99 references indexed in Scilit:
- Understanding painClinical Medicine, 2001
- Antidepressants and Anticonvulsants for Diabetic Neuropathy and Postherpetic Neuralgia: A Quantitative Systematic ReviewJournal of Pain and Symptom Management, 2000
- Anticonvulsants for Neuropathic Pain SyndromesDrugs, 2000
- Overview of neuropathic pain syndromesActa Neurologica Scandinavica, 1999
- TopiramateEpilepsia, 1999
- MexiletineDrugs, 1998
- Double-blind, placebo-controlled study of the application of capsaicin cream in chronic distal painful polyneuropathyPain, 1995
- Lidocaine test in neuralgiaPain, 1992
- Sorbitol, Phosphoinositides, and Sodium-Potassium-ATPase in the Pathogenesis of Diabetic ComplicationsNew England Journal of Medicine, 1987
- Intravenous lidocaine infusion — a new treatment of chronic painful diabetic neuropathy?Pain, 1987